GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant

Diffuse hemispheric gliomas, H3G34R/V-mutant (DHG-H3G34), are lethal brain tumors lacking targeted therapies. They originate from interneuronal precursors; however, leveraging this origin for therapeutic insights remains unexplored. Here, we delineate a cellular hierarchy along the interneuron lineage development continuum, revealing that DHG-H3G34 mirror spatial patterns of progenitor streams surrounding interneuron nests, as seen during human brain development. Integrating these findings with genome-wide CRISPR-Cas9 screens identifies genes upregulated in interneuron lineage progenitors as major dependencies. Among these, CDK6 emerges as a targetable vulnerability: DHG-H3G34 tumor cells show enhanced sensitivity to CDK4/6 inhibitors and a CDK6-specific degrader, promoting a shift toward more mature interneuron-like states, reducing tumor growth, and prolonging xenograft survival. Notably, a patient with progressive DHG-H3G34 treated with a CDK4/6 inhibitor achieved 17 months of stable disease. This study underscores interneuronal progenitor-like states, organized in characteristic niches, as a distinct vulnerability in DHG-H3G34, highlighting CDK6 as a promising clinically actionable target.

Authors

Institutions

Publication Details

Journal
Cancer Cell
Published
2024-09-01
DOI
https://doi.org/10.1016/j.ccell.2024.08.006
Citations
45
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
19.71
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant

Tara Barron, Carl Koschmann, Mariella G. Filbin, Emelie Braun et al.
45 citations
Cancer Cell
Glioma Diagnosis and Treatment
19.71
article

GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant

Tara Barron, Carl Koschmann, Mariella G. Filbin, Emelie Braun, Sanda Alexandrescu, Angela Mastronuzzi, Kristina A. Cole, Cristina Bleil, Rodrigo T. Cartaxo, Maria Vinci, Keith L. Ligon, Ilon Liu, Darren Hargrave, Angela J. Waanders, Yura Grabovska, McKenzie Shaw, Rebecca D. Hodge, Gustavo Alencastro Veiga Cruzeiro, Irene Slavc, Michelle Monje, Hafsa M. Mire, Fernando Carceller, Sibylle Madlener, Chris Jones, Valeria Molinari, Johannes Gojo, Alexander Beck, Kimberly Siletti, Alan Mackay, Jenna LaBelle, Bernhard Englinger, Marta Pérez‐Somarriba, Sara Temelso, Olivia A. Hack, Samantha E. Hoffman, Sameer Agnihotri, Andrezza Nascimento, Florence I. Raynaud, Christian Dorfer, Ruth Ruddle, Giulia Pericoli, Jacob S Rozowsky, Michael A. Quezada, David D. Eisenstat, Rene Geyeregger, Ulrich Schüller, Lijuan Hu, Gerda Ricken, Quang‐Dé Nguyen, Rebecca F. Rogers, Murry Morrow, Alicia-Christina Baumgartner, Eshini Panditharatna, Sina Neyazi, Christine Haberler, Miri Danan-Gotthold, Ed S. Lein, Amy Cameron, Sten Linnarsson, Benison Lau, Christopher Rota, Lisa Mayr, Ángel M. Carcaboso, Erik Sundström, Jiang Li, Andrew King, Sophia Castellani, Santhosh Uphadhyaya, Rebecca Haase, Lynn Bjerke, Simon Stapleton
article en
45 citations

Abstract

Diffuse hemispheric gliomas, H3G34R/V-mutant (DHG-H3G34), are lethal brain tumors lacking targeted therapies. They originate from interneuronal precursors; however, leveraging this origin for therapeutic insights remains unexplored. Here, we delineate a cellular hierarchy along the interneuron lineage development continuum, revealing that DHG-H3G34 mirror spatial patterns of progenitor streams surrounding interneuron nests, as seen during human brain development. Integrating these findings with genome-wide CRISPR-Cas9 screens identifies genes upregulated in interneuron lineage progenitors as major dependencies. Among these, CDK6 emerges as a targetable vulnerability: DHG-H3G34 tumor cells show enhanced sensitivity to CDK4/6 inhibitors and a CDK6-specific degrader, promoting a shift toward more mature interneuron-like states, reducing tumor growth, and prolonging xenograft survival. Notably, a patient with progressive DHG-H3G34 treated with a CDK4/6 inhibitor achieved 17 months of stable disease. This study underscores interneuronal progenitor-like states, organized in characteristic niches, as a distinct vulnerability in DHG-H3G34, highlighting CDK6 as a promising clinically actionable target.

Cancer CellVol. 42(9)
Broad Institute (US), Boston Children's Hospital (US), Lurie Children's Hospital (US), Hospital Sant Joan de Déu Barcelona (ES), Allen Institute for Brain Science (US), Royal Marsden NHS Foundation Trust (GB), Children's Hospital of Philadelphia (US), Howard Hughes Medical Institute (US), Harvard University (US), Institute of Cancer Research (GB), Universität Hamburg (DE), The University of Melbourne (AU), University of Michigan (US), Great Ormond Street Hospital (GB), Karolinska Institutet (SE), Humboldt-Universität zu Berlin (DE), Comprehensive Cancer Center Vienna (AT), University Medical Center Hamburg-Eppendorf (DE), King's College Hospital NHS Foundation Trust (GB), St George's Hospital (GB), Dana-Farber Cancer Institute (US), Cancer Research Institute of the Slovak Academy of Sciences (SK), Royal Marsden Hospital (GB), Bambino Gesù Children's Hospital (IT), Children's Hospital of Pittsburgh (US), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Allen Institute (US), Murdoch Children's Research Institute (AU), King's College Hospital (GB), Institute of Neurobiology (BG), Dana-Farber Brigham Cancer Center (US), Dana-Farber/Boston Children's Cancer and Blood Disorders Center (US), Imaging Center (US), University College London (GB), Community College of Rhode Island (US), Medical University of Vienna (AT), Charité - Universitätsmedizin Berlin (DE), Ludwig-Maximilians-Universität München (DE), Stanford University (US)
Good health and well-being
Openalex Percentile: Top 0%
Glioma Diagnosis and Treatment
19.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.